LVS CEO exercises 900,000 options at $34.28, sells shares

Las Vegas Sands (LVS) filed a Form 4 for Chairman & CEO Robert G. Goldstein.

Rhea-AI Filing Summary

Las Vegas Sands (LVS) filed a Form 4 for Chairman & CEO Robert G. Goldstein. He exercised options at $34.28 for 700,000 shares on 10/29/2025 and 200,000 shares on 10/30/2025, then sold 532,993 shares at a weighted average price of $58.77 (range $58.11–$59.10), 167,007 shares at $59.22 (range $59.11–$59.40), and 200,000 shares at $59.05 (range $58.77–$59.32).

Following these transactions, 129,005 shares were held indirectly by The Robert and Sheryl Goldstein Trust. Table II shows 800,000 options beneficially owned following the reported transactions. Remarks note additional holdings of vested options to purchase 3,300,000 shares and 403,800 unvested restricted stock units.

Insider Trade Summary

Exercise and Sale: 900,000 shares ($22.17M approx. pre-tax spread)

Exercise and Sale 8 txns

Insider Goldstein Robert G

Role Chairman & CEO

Sold 900,000 shs ($53.02M)

Approx. gross sale proceeds $53.02M

Approx. exercise cost $30.85M

Approx. pre-tax spread $22.17M

Type	Security	Shares	Price	Value
Exercise	Option (Right to Buy)	200,000	$0.00	$0.00
Exercise	Common Stock	200,000	$34.28	$6.86M
Sale	Common Stock	200,000	$59.05	$11.81M
Exercise	Option (Right to Buy)	700,000	$0.00	$0.00
Exercise	Common Stock	700,000	$34.28	$24.00M
Sale	Common Stock	532,993	$58.77	$31.32M
Sale	Common Stock	167,007	$59.22	$9.89M
holding	Common Stock	--	--	--

Holdings After Transaction: Option (Right to Buy) — 800,000 contracts (Direct); Common Stock — 0 shares (Direct); Common Stock — 129,005 shares (Indirect, By The Robert and Sheryl Goldstein Trust)

Footnotes (4)

1. F1. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $58.11 to $59.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
2. F2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $59.11 to $59.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
3. F3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $58.77 to $59.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
4. F4. These options vested in three equal annual installments beginning on December 3, 2022.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did LVS’s CEO report on Form 4?

He exercised options at $34.28 for 900,000 shares and sold those shares in market transactions at weighted average prices around $59.

How many shares did Robert G. Goldstein sell and at what prices?

He sold 532,993 at $58.77, 167,007 at $59.22 on 10/29/2025, and 200,000 at $59.05 on 10/30/2025.

What shares remain held after the reported transactions?

The filing lists 129,005 shares held indirectly by The Robert and Sheryl Goldstein Trust.

What derivative holdings remain after these transactions?

Table II shows 800,000 options beneficially owned following the transactions.

Were the sales reported as weighted average prices?

Yes. The filing provides weighted average prices and ranges for each sale date, with an undertaking to provide full breakdowns upon request.

Do remarks disclose additional equity awards?

Yes. Remarks note 3,300,000 vested options and 403,800 unvested restricted stock units.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/31/2025 - 06:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Goldstein Robert G

(Last) (First) (Middle)

5420 S. DURANGO DRIVE

(Street)

LAS VEGAS NV 89113

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LAS VEGAS SANDS CORP [ LVS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chairman & CEO

3. Date of Earliest Transaction (Month/Day/Year)
10/29/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/29/2025		M		700,000	A	$34.28	700,000	D
Common Stock	10/29/2025		S		532,993	D	$58.77(1)	167,007	D
Common Stock	10/29/2025		S		167,007	D	$59.22(2)	0	D
Common Stock	10/30/2025		M		200,000	A	$34.28	200,000	D
Common Stock	10/30/2025		S		200,000	D	$59.05(3)	0	D
Common Stock								129,005	I	By The Robert and Sheryl Goldstein Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (Right to Buy)	$34.28	10/29/2025		M			700,000	(4)	12/02/2031	Common Stock	700,000	$0	1,000,000	D
Option (Right to Buy)	$34.28	10/30/2025		M			200,000	(4)	12/02/2031	Common Stock	200,000	$0	800,000	D

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $58.11 to $59.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $59.11 to $59.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $58.77 to $59.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

4. These options vested in three equal annual installments beginning on December 3, 2022.

Remarks:

In addition to the options exercised and the underlying shares sold on October 29, 2025 and October 30, 2025, Mr. Goldstein holds options to purchase 3,300,000 shares that are vested and 403,800 restricted stock units that are unvested.

	/s/ Judy Tomkins, Attorney-in-Fact	10/31/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.